MedTrace Logo

Assessment of Intracellular Cytokines and Markers in Cells (Phase 3)

NCT03896100 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2019-10-16

No results posted yet for this study

Summary

This is a single arm, prospective, bilateral, non-randomized study that will be split into four elements. Element 1 will be an in vitro non-clinical study and described in the laboratory protocol. Elements 2, 3 and 4 will each be a single non-dispensing visit.

Conditions

  • Impression Cytology

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-28
Primary Completion
2019-09-15
Completion
2019-09-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03896100 on ClinicalTrials.gov